DNA Script–Agilent: investment, 202110 financing round Series C totalling $165m incl existing + co-investor Agilent Technologies |
2021-10-26 |
DNA Script–Danaher: investment, 202110 financing round Series C totalling $165m incl existing + co-investor Danaher Life Sciences |
2021-10-26 |
DNA Script–SEVERAL: investment, 202110 financing round Series C $165m co-led by Coatue Management + Catalio Capital Management |
2021-10-26 |
TrueMass–Scott Partnership: public relations, 202110 service existent by Scott PR |
2021-10-26 |
QInstruments–Bico: investment, 202110 acquisition 100% cash/debt free for €58.25m upfront + €3m milestones thereof 13% paid in new Bico shares |
2021-10-01 |
Thermo Fisher–Carbon Engineering: analytical technology, 202109 collab existent direct air capture technology to reduce CO2 emissions |
2021-09-23 |
Hurel–Bico: investment, 202109 acquisition $2.5m of assets + operations of Hurel Corp + integration in Visikol |
2021-09-15 |
Agena Bioscience–Mesa Labs: investment, 202109– acquisition $300m in cash of Agena by Mesa Laboratories ANNOUNCED |
2021-09-14 |
De Novo Software–Insightful Science: investment, 202109 acquisition of De Novo Software by Insightful Science |
2021-09-14 |
Evotec–Biognosys: MS-based proteomics, 202109– collab integration of Spectronaut proteomics data analys into drug discovery + clinical proteomics |
2021-09-14 |
Owlstone–Horizons Ventures: investment, 202109 financing round Series D totalling $58m incl existing + lead investor Horizons Ventures |
2021-09-07 |
Owlstone–SEVERAL: investment, 202109 financing round Series D $58m of Owlstone Medical led by existing investor Horizons Ventures |
2021-09-07 |
Biognosys–ETH Zürich: LiP technology, 202108 collab developm + excl license from Institute of Systems Biology |
2021-08-27 |
Atavistik Bio–Column Group: investment, 202108 financing round Series A totalling $60m incl lead investor The Columm Group |
2021-08-24 |
Atavistik Bio–Lux Capital: investment, 202108 financing round Series A totalling $60m incl co-investor Lux Capital |
2021-08-24 |
Atavistik Bio–Nextech: investment, 202108 financing round Series A totalling $60m incl co-investor Nextech Invest Ltd |
2021-08-24 |
Atavistik Bio–SEVERAL: investment, 202108 financing round Series A $60m led by The Columm Group with Lux Capital + Nextech Invest |
2021-08-24 |
Thermo Fisher–ChromSword: HPLC software, –202108 collab developm + launch of Vanquish Method Development HPLC + UHPLC system using ChromSword s/w |
2021-08-16 |
Spectricity–SEVERAL: investment, 202108 financing round Series B €14m |
2021-08-03 |
Nuvisan–ALS Ltd: investment, 202207 strategic investment acquiring 49% stake in Nuvisan to expand ALS Life Sciences network |
2021-07-28 |
BioLegend–PerkinElmer: investment, 202107– acquisition $5.25b in cash + shares subject to certain adjustments ANNOUNCED |
2021-07-26 |
Excellims–Covalent Bonds: public relations, 202107 service existent by Covalent Bonds |
2021-07-21 |
Mobilion–Agilent: investment, 202107 financing round Series C totalling $60m incl existing + co-investor Agilent Technologies |
2021-07-13 |
Mobilion–aMoon: investment, 202107 financing round Series C totalling $60m incl existing + co-investor aMoon |
2021-07-13 |
Mobilion–Cultivation Capital: investment, 202107 financing round Series C totalling $60m incl existing + co-investor Cultivation Capital |
2021-07-13 |
Mobilion–D1 Capital: investment, 202107 financing round Series C totalling $60m incl new + lead investor D1 Capital Partners |
2021-07-13 |
Mobilion–Hostplus: investment, 202107 financing round Series C totalling $60m incl existing + co-investor Hostplus |
2021-07-13 |
Mobilion–IP Group: investment, 202107 financing round Series C totalling $60m incl existing + co-investor IP Group |
2021-07-13 |
Mobilion–SEVERAL: investment, 202107 financing round Series C $60m led by new investor D1 Capital Partners |
2021-07-13 |
Sygnature Discovery–Rothschild & Co: investment, 202106 significant €na investment by Five Arrows Principal Investments |
2021-06-29 |
Discover Echo–Cellink: investment, 202106– acquisition $110m with $98m in cash + $12m in new Series B shares ANNOUNCED |
2021-06-26 |
Paramit–Tecan: investment, 202106– acquisition $1b from Altaris Capital Partners LLC ANNOUNCED |
2021-06-23 |
908 Devices–Sartorius: bioprocess control technology, 202106 collab product integration Rebel media analyzer with SIMCA data exploratory tool |
2021-06-22 |
908 Devices–Securecell: bioprocess control technology, 202106 collab product integration Rebel media analyzer with Lucullus PIMS |
2021-06-22 |
Sirion Biotech–PerkinElmer: investment, 202106– acquisition by PerkinElmer ANNOUNCED |
2021-06-22 |
Aldevron–Danaher: investment, 202106– acquisition $9.6b in cash by Danaher ANNOUNCED |
2021-06-17 |
Chemic Laboratories–Solvias: investment, 202106 acquisition €na by Solvias |
2021-06-17 |
IonSense–Covalent Bonds: public relations, 202106 service existent by Covalent Bonds |
2021-06-03 |
Celonis–SEVERAL: investment, 202106 financing round Series D $1b co-led by Durable Capital Partners + T Rowe Price |
2021-06-02 |
Danaher–Celonis: management execution software, 202106 supply existent customer Danaher Corp |
2021-06-02 |
GoSilico–Danaher: investment, 202106 acquisition of GoSilico GmbH by Cytiva |
2021-06-02 |
Univ Belfast–Agilent: grant, 202106– Thought Leader Award to Prof Chris Elliott at QUB IGFS for food safety analysis |
2021-06-01 |
Univ Belfast–Agilent: LC system, 202106 supply 1290 Infinity II LC System as part of Thought Leader Award grant to QUB IGFS |
2021-06-01 |
Univ Belfast–Agilent: mass spectrometer, 202106 supply 6546 LC-Q/TOF instrument as part of Thought Leader Award grant to QUB IGFS |
2021-06-01 |
Univ Belfast–Agilent: mass spectrometer, 202106 supply 7850 ICP-MS instrument as part of Thought Leader Award grant to QUB IGFS |
2021-06-01 |
Immunodiagnostic Systems–PerkinElmer: investment, 202105– recommended all cash offer £110m by PerkinElmer ANNOUNCED |
2021-05-17 |
Nexcelom Bioscience–PerkinElmer: investment, 202105– acquisition $260m in cash from founders + Ampersand Capital Partners |
2021-05-12 |
Danaher–Waters: LC systems, 202105– collab co-marketing Sciex offers MS systems interoperable with UPLC systems from Waters |
2021-05-11 |
Agendia–Inivata: cancer test, 202104– co-excl distribution rights €na for RaDaR liquid biopsy assay for breast cancer in North America + Europe |
2021-04-28 |
HexagonFab–SEVERAL: investment, 202104 seed financing round £1.9m led by Cambridge Enterprise |
2021-04-20 |
Siemens–Biognosys: MS-based biomarker discovery, 202104– strategic agreem marker discovery using HRM-MS for Dx assay development with S Healthineers |
2021-04-13 |
Swift Biosciences–Danaher: investment, 202103 acquisition €na of Swift Biosciences by Integrated DNA Technologies |
2021-03-11 |
Resolution Bioscience–Agilent: investment, 202103–202104 acquisition $550m cash at closing + $145m milestones of Resolution Bioscience by Agilent |
2021-03-02 |
Cognate BioServices–Charles River: investment, 202102–202103 acquisition $875m in cash by Charles River |
2021-02-17 |
Thermo Fisher–Sidis: cell sorting technology, 202102 acquisition cell sorting assets incl Bigfoot Spectral Cell Sorter + 40 employees from Propel Labs |
2021-02-17 |
Inivata–Farallon Capital: investment, 202102 financing round Series C 2nd closing totalling $35m incl new + co-investor Farallon Capital |
2021-02-04 |
Inivata–IP Group: investment, 202102 financing round Series C 2nd closing totalling $35m incl existing + co-investor IP Group |
2021-02-04 |
Inivata–Janus Henderson: investment, 202102 financing round Series C 2nd closing totalling $35m incl new + co-investor Janus Henderson Investors |
2021-02-04 |
Inivata–SEVERAL: investment, 202102 financing round Series C 2nd closing $35m led by Soleus Capital bringing total Series C to $60m |
2021-02-04 |
Inivata–Soleus Capital: investment, 202102 financing round Series C 2nd closing totalling $35m incl new + lead investor Soleus Capital |
2021-02-04 |
Tecan–UgenTec: laboratory automation, 202102– collab product integration of Tecan workstations with FastFinder qPCR-s/w for sale in dx markets |
2021-02-04 |
Danaher–Scitara: laboratory software, 202102– license + collab product integration of Scitara DLX platform with IDBS Polar platform |
2021-02-02 |
Avacta–Adeptrix: MS-based SARS-CoV-2 test, 202101 collab existent developm of BAMS SARS-CoV-2 assay for research + IVD |
2021-01-28 |
Avacta–Bruker: MS-based SARS-CoV-2 test, 202101– collab developm of BAMS SARS-CoV-2 assay on Bruker MALDI-TOF as IVD test |
2021-01-28 |
Scitara–Flybridge Capital: investment, 202101 financing round Series A totalling $5m incl existing + co-investor Flybridge Capital |
2021-01-28 |
Scitara–Northpond Ventures: investment, 202101 financing round Series A totalling $5m incl lead investor Northpond Ventures |
2021-01-28 |
Scitara–SEVERAL: investment, 202101 financing round Series A $5m led by Northpond Ventures |
2021-01-28 |
Mobilion–Protein Metrics: mass spectrometry software, 202101– collab integration of Byos software suit with Mobilion HRIM MS system |
2021-01-26 |
i3 Membrane–High-Tech Gründerfonds: investment, 202101 financing round totalling 7-figure € sum inkl existing investor HTGF |
2021-01-25 |
i3 Membrane–OTHER: investment, 202101 financing round totalling 7-figure € sum incl three private investors |
2021-01-25 |
i3 Membrane–SEVERAL: investment, 202101 financing round 7-figure € sum from HTGF + three private investors |
2021-01-25 |
Intabio–Danaher: investment, 202101 acquisition $na of Intabio Inc by Sciex |
2021-01-21 |
Numares–Bruker: NMR spectroscopy, 202102– collab developm + product integration Axinon platform for metabolomics-based NMR-CDx |
2021-01-21 |
Mesa Biotech–Thermo Fisher: investment, 202101– acquisition $450m cash upfront + $100m cash milestones of Mesa Biotech Inc by Thermo Fisher |
2021-01-19 |
Novasep–Thermo Fisher: investment, 202101 acquisition €725m in cash of viral vector manufacturing business Henogen SA in Belgium by Thermo Fisher |
2021-01-15 |
Labforward–2mag: investment, 202101 financing round Series B totalling >€5m incl new + co-investor 2mag |
2021-01-11 |
Labforward–Peppermint: investment, 202101 financing round Series B totalling >€5m incl existing + co-investor Peppermint VenturePartners |
2021-01-11 |
Labforward–SEVERAL: investment, 202101 financing round Series B >€5m led by Tecan + incl 2mag + Peppermint VenturePartners |
2021-01-11 |
Labforward–Tecan: investment, 202101 financing round Series B totalling >€5m incl €4m from new + lead investor Tecan resulting in 10% stake |
2021-01-11 |
IsoPlexis–SEVERAL: credit, 202101– credit facility $50m |
2021-01-07 |
IsoPlexis–SEVERAL: investment, 202101 financing round Series D $85m led by new investor Perceptive Advisors |
2021-01-07 |
Oxford Immunotec–PerkinElmer: investment, 202101– acquisition $591m with $22/share in cash ANNOUNCED |
2021-01-07 |
Adeptrix–Bruker: investment, 202101 financing round Series A incl new + minority investor Bruker Corp |
2021-01-06 |
Adeptrix–SEVERAL: investment, 202101 financing round Series A closed with new + minority investor Bruker Corp |
2021-01-06 |
Novasep–Sartorius: investment, 202101– acquisition €na of Novasep’s chromatography process equipment division by Sartorius ANNOUNCED |
2021-01-06 |
Distributed Bio–Charles River: investment, 202012 acquisition $83m upfront cash + $21m milestones |
2020-12-31 |
Phitonex–Thermo Fisher: investment, 202012 acquisition fo Phitonex by Thermo Fisher Scientific |
2020-12-31 |
SomaLogic–Amgen: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Amgen |
2020-12-22 |
SomaLogic–Boston Millennia Partners: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Boston Millenia Partners |
2020-12-22 |
SomaLogic–Intermountain Ventures: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Intermountain Ventures |
2020-12-22 |
SomaLogic–Janus Henderson: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Janus Henderson Investors |
2020-12-22 |
SomaLogic–Logos Capital: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Logos Capital |
2020-12-22 |
SomaLogic–Millenium Management: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Millennium Management |
2020-12-22 |
SomaLogic–NEC: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl NEC Solution Innovators Ltd |
2020-12-22 |
SomaLogic–Novartis: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Novartis |
2020-12-22 |
SomaLogic–Redmile Group: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Redmile Group |
2020-12-22 |
SomaLogic–Revelation Partners: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Revelation Partners |
2020-12-22 |
SomaLogic–SEVERAL: investment, 202012 financing round Series A 2nd closing additional $81m bringing total Series A to $204m or $214m |
2020-12-22 |
SomaLogic–Ziff Capital: investment, 202012 financing round Series A 2nd closing totalling addit $81m incl Ziff Capital Healthcare Ventures |
2020-12-22 |
908 Devices–SEVERAL: investment, 202012 IPO $130m+$19.5m net $136.6m with 6.5m+975k shares common stock at $20/share at Nasdaq Global Market |
2020-12-18 |